Molecular Advances and Therapeutic Strategies in Renal Failure
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (20 November 2024) | Viewed by 5217
Special Issue Editor
Interests: renal failure; Anderson Fabry disease; vasculopaties
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue titled “Molecular Advances and Therapeutic Strategies in Renal Failure” will mainly cover several aspects regarding molecular and/or cellular mechanisms of renal cell injury leading to (acute or chronic) renal failure, providing us with a platform to potentially build/design specific therapeutic strategies that can prevent/cure those syndromes which are commonly faced by Nephrologists. The increase in their prevalence is due to the populations’ average age progressively increasing and; diabetic and cardiovascular diseases also increasing worldwide; and the large use/abuse of nephrotoxic drugs or agents, such as, for example, radiocontrast media administration.
This Special Issue is also open to considering manuscripts containing novel (including molecular) findings and/or reports (regarding novel therapeutic strategies) regarding patients undergoing dialysis, as well as regarding different genetic (renal) diseases that are often faced by Nephrologists (but also by other Specialists too), such as ADPKD, Alport’s Syndrome and Anderson-Fabry Disease, which can all often lead to chronic renal failure.
Prof. Dr. Michele Andreucci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- intracellular signaling
- cell death
- cell survival
- gene
- treatment
- mortality
- uremia
- dialysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
